insights_auto
Why is TWST down 2.31%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
$152.05
arrow_downward
-2.31%(-3.60) 1D
$152.05
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$148.00
High
$152.59
Low
$144.60
Mkt. cap
10.08B
Avg. vol.
2.46M
Volume
4.21M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
Open
$148.00
High
$152.59
Low
$144.60
Mkt. cap
10.08B
Avg. vol.
2.46M
Volume
4.21M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
GuruFocus
·
6 hours ago
TWST Initiates Coverage On Jefferies -- Rating Set to Hold
TipRanks
·
6 hours ago
Why Twist Bioscience’s Hot Stock Is Suddenly Sinking
Benzinga
·
7 hours ago
This Generac Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Seeking Alpha
·
8 hours ago
Twist Bioscience: Valuation Stretched As AI Drug Discovery Hype Outpaces Reality (TWST)
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp